| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/17/2008 | US20080015209 Compounds for the treatment of metabolic disorders |
| 01/17/2008 | US20080015204 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015202 Thiazole Derivatives Having Vap-1 Inhibitory Activity |
| 01/17/2008 | US20080015200 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015175 Nontoxic; inhibition of interleukin-1 beta -converting enzyme |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080014287 Micronutrient Combination Product For Use As A Dietetic Food Supplement In Age-Related Macular Degeneration |
| 01/17/2008 | US20080014249 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 01/17/2008 | US20080011293 Stable Xylometazoline and Oxymetazoline Solution |
| 01/17/2008 | CA2659121A1 Therapeutic compounds |
| 01/17/2008 | CA2658241A1 Scfv antibodies which pass epithelial and/or endothelial layers |
| 01/17/2008 | CA2657719A1 Cyclopentane derivatives as antiglaucoma agents |
| 01/17/2008 | CA2657625A1 Therapeutic compounds |
| 01/17/2008 | CA2657308A1 Treatment of excessive neovascularization |
| 01/17/2008 | CA2654146A1 Composition for improving eye health |
| 01/16/2008 | EP1878748A2 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 costimulatory antigens |
| 01/16/2008 | EP1878734A1 Novel lactam compound |
| 01/16/2008 | EP1878732A1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR |
| 01/16/2008 | EP1878446A2 Formulation comprising buprenorphine |
| 01/16/2008 | EP1877372A1 Water-dispersible carotenoids, including analogs and derivatives |
| 01/16/2008 | EP1877066A1 Use of azithromycin for the production of a medicament for treatment of ocular infections |
| 01/16/2008 | EP1877051A1 MATRIX METALLOPROTEINASE INHIBITORS OF TGFß -INDUCED SUBCAPSULAR CATARACT FORMATION |
| 01/16/2008 | EP1492793B1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/16/2008 | EP1370254B1 Copper chelators for treating ocular inflammation |
| 01/16/2008 | EP1223981B1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 01/16/2008 | CN101107225A 12-aryl prostaglandin analogs |
| 01/16/2008 | CN101107014A Stabilisation of glucocorticoid esters with acids |
| 01/16/2008 | CN101107005A CRIg polypeptide for prevention and treatment of complement-associated disorders |
| 01/16/2008 | CN101103992A Azithromycin eye drops and preparing process thereof |
| 01/16/2008 | CN100361661C Stable eye lotion containing latanoprost as active ingredient |
| 01/16/2008 | CN100361658C In situ-forming eye gel composition of ganciclovir and preparation method thereof |
| 01/16/2008 | CN100361657C Fluorouracial nano particle formulation and its preparing method |
| 01/15/2008 | US7319160 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 01/15/2008 | US7319107 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 01/15/2008 | CA2210684C Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 01/15/2008 | CA2123405C Angiostatic steroids |
| 01/10/2008 | WO2008006052A2 Bicyclic heteroaryl inhibitors of pde4 |
| 01/10/2008 | WO2008006051A2 Bicyclic heteroaryl inhibitors of pde4 |
| 01/10/2008 | WO2008006050A2 Bicyclic heteroaryl inhibitors of pde4 |
| 01/10/2008 | WO2008006046A1 Ceramide composition and use thereof in treatment of ocular diseases |
| 01/10/2008 | WO2008005035A1 Porous polymeric articles |
| 01/10/2008 | WO2008004948A1 8-oxoadenine derivatives acting as modulators of tlr7 |
| 01/10/2008 | WO2008003242A1 Method and ophthalmic formulation for eye protection or treatment |
| 01/10/2008 | WO2007060458A3 Treatment of ophthalmic diseases with beta-amino alcohols |
| 01/10/2008 | US20080009520 Benzimidazolidinone derivatives as muscarinic agents |
| 01/10/2008 | US20080009501 Methods for treating neoplastic, angiogenic, fibroblastic, and/or immunosuppressive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicaments |
| 01/10/2008 | US20080009476 Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva |
| 01/10/2008 | US20080009471 Ocular delivery of triamcinolone acetonide phosphate and related compounds |
| 01/10/2008 | US20080009463 Method of treating dry eye disease with purinergic receptor agonists |
| 01/10/2008 | US20080009453 Pharmceutical Compositions Containing Polydatin or Its Salts and Their Application |
| 01/10/2008 | US20080009441 Polypeptide Inducing the Secretion of Angiopoietin |
| 01/10/2008 | US20080009437 Pharmaceutical Compositions and Method for Treating Dry Eye |
| 01/10/2008 | US20080009436 Eye-drops suitable for the treatment of diseases of the eye and surrounding areas; cyclosporin A, castor oil, and Polyoxyethylene 20 (POE (20)) sorbitan monolaurate |
| 01/10/2008 | US20080008762 Steroid Formulation And Methods Of Treatment Using Same |
| 01/10/2008 | US20080008749 Ceramide composition and method of use |
| 01/10/2008 | US20080008698 Non-Surgical Method for Preventing or Reducing the Rate of the Progression of Non-Proliferative Diabetic Retinopathy and the Treatment of Other Ocular Conditions |
| 01/10/2008 | CA2657093A1 Bicyclic heteroaryl inhibitors of pde4 |
| 01/10/2008 | CA2656183A1 Modulators of muscarinic receptors |
| 01/10/2008 | CA2656170A1 Infant formulas for early brain development |
| 01/09/2008 | EP1876239A1 Degranulation inhibitor |
| 01/09/2008 | EP1876175A1 Therapeutic agent for corneal disease |
| 01/09/2008 | EP1875922A2 Intestinal trefoil proteins |
| 01/09/2008 | EP1874118A2 Materials and methods for enhanced degradation of mutant proteins associated with human disease |
| 01/09/2008 | EP1527068B1 Novel arylimidazole derivatives, their use as no-syntase inhibitors and as modulators of sodium channels |
| 01/09/2008 | EP1283043B1 Ophthalmic solution |
| 01/09/2008 | EP1263730B1 Amine derivatives for the treatment of apoptosis |
| 01/09/2008 | EP1115416B1 Use of substances with oxytocin activity in order to create cell regeneration |
| 01/09/2008 | CN101102989A Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions |
| 01/09/2008 | CN101102778A Substance mixture |
| 01/09/2008 | CN101102773A Aminopyrazine analogs for treating glaucoma and other RHO kinase-mediated diseases |
| 01/09/2008 | CN101100689A Method for preparing pearl active peptide |
| 01/09/2008 | CN101099569A Vaccinium beacteatum Thunb freeze-dried powder injection and its preparation method and application |
| 01/09/2008 | CN100360521C 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 01/09/2008 | CN100360505C Quinazoline derivatives as angiogenesis inhibitors |
| 01/09/2008 | CN100360183C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 01/09/2008 | CN100360180C Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 01/09/2008 | CN100360175C Pharmatceutical Formualtion comprising cyclosporin and use thereof |
| 01/09/2008 | CN100360174C Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (t beta 4), analogues, isoforms and other derivatives |
| 01/08/2008 | US7317040 Nitric oxide synthase inhibitor phosphate salt |
| 01/08/2008 | US7317038 1,3-Diacetyl-8-hydroxy-2-(7-hydroxychromanon-3-yl)-9H-xanthen-9-ones; obtained from a culture of the Penicillium strain SPF-3059; prevents growth cone collapse |
| 01/08/2008 | US7317036 Prostaglandins for prostaglandin mediated diseases such as antihistamines |
| 01/08/2008 | US7317035 Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/08/2008 | CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 01/08/2008 | CA2348474C Pharmaceutically active composition and dispensing device |
| 01/03/2008 | WO2008002582A2 Ultraviolet absorbing ophthalmic compositions |
| 01/03/2008 | WO2008001959A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 01/03/2008 | WO2008001872A1 Ophthalmic composition containing alginic acid or salt thereof |
| 01/03/2008 | WO2007113698A3 Preventative treatment and remission of allergic diseases |
| 01/03/2008 | WO2007070866A3 Control of intraocular pressure using alk5 modulation agents |
| 01/03/2008 | US20080004371 Radiopaque Animal Chew |
| 01/03/2008 | US20080004311 Histone deacetylase inhibitors for treating degenerative diseases of the eye |
| 01/03/2008 | US20080004267 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | US20080004251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor |
| 01/03/2008 | US20080004246 Transporter enhanced corticosteroid activity |
| 01/03/2008 | US20080004231 Disease-Associated Protein |
| 01/03/2008 | US20080003310 Eye drops |
| 01/03/2008 | US20080003271 Moisturizing, cosmetic, or anti-wrinkle composition comprising at least two hyaluronic acid fractions or salts thereof, wherein first fraction has molecular weight of 8,000-100,000 Da, and second fraction has molecular weight of 500,000-1,100,000 Da; may also have use in treating osteoarthritis, cancer |
| 01/03/2008 | US20080003260 Use of 5-fluorourcil, delivered by iontophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skin |